Fundz

SenzaGen acquires Alcyomics for drug development

PRIVATEOct 28, 2026

Acquiring Company

SenzaGen AB

Acquired Company

Alcyomics Ltd

LundNewcastle Upon TyneBiotechnologyBiotechnology

Description

SenzaGen AB has entered into an agreement to acquire Alcyomics Ltd. This acquisition enhances SenzaGen's portfolio by adding Alcyomics' expertise in non-animal testing methods.

Who to call at SenzaGen AB, and when

When SenzaGen AB changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day SenzaGen AB raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SenzaGen AB, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SenzaGen AB. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SenzaGen AB

Location

Lund, Skåne County, Sweden

About

SenzaGen AB is a biotechnology company specializing in non-animal safety testing to support drug development. The company aims to enhance biomedical research through innovative solutions in immunotoxicology testing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SenzaGen AB makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for SenzaGen AB's next move

Learn about Strategic plan

Frequently asked

Who acquired Alcyomics Ltd?

Alcyomics Ltd was acquired by SenzaGen AB, based in Lund. The deal was reported on October 28, 2026. SenzaGen AB is a biotechnology company specializing in non-animal safety testing to support drug development. The company aims to enhance biomedical research through innovative solutions in immunotoxicology testing. SenzaGen AB is privately held and operates in Biotechnology.

When did SenzaGen AB acquire Alcyomics Ltd?

SenzaGen AB's acquisition of Alcyomics Ltd was reported on October 28, 2026. SenzaGen AB has entered into an agreement to acquire Alcyomics Ltd. This acquisition enhances SenzaGen's portfolio by adding Alcyomics' expertise in non-animal testing methods. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Alcyomics Ltd do?

Alcyomics Ltd is a leading provider of non-animal immunotoxicology solutions for pharmaceuticals in the preclinical phase. The company focuses on biological anti-cancer drugs and utilizes human-based test platforms for safety testing. It is privately held, operating in Biotechnology, and is based in Newcastle Upon Tyne.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.